

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 4.52422065 |
| 2 | response to peptidoglycan (GO:0032494) | 4.28400475 |
| 3 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.03400585 |
| 4 | glycolipid catabolic process (GO:0019377) | 4.03231286 |
| 5 | amino sugar catabolic process (GO:0046348) | 3.99567284 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 3.92690193 |
| 7 | oligosaccharide catabolic process (GO:0009313) | 3.90069458 |
| 8 | regulation of leukocyte degranulation (GO:0043300) | 3.88170772 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.85222532 |
| 10 | negative regulation of interleukin-12 production (GO:0032695) | 3.83568855 |
| 11 | mannose metabolic process (GO:0006013) | 3.80621471 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 3.77754686 |
| 13 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.68163444 |
| 14 | positive regulation of mast cell degranulation (GO:0043306) | 3.64007229 |
| 15 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.64007229 |
| 16 | positive regulation of mast cell activation (GO:0033005) | 3.63674123 |
| 17 | protein localization to endosome (GO:0036010) | 3.60609684 |
| 18 | regulation of mast cell degranulation (GO:0043304) | 3.59911462 |
| 19 | regulation of regulated secretory pathway (GO:1903305) | 3.54556589 |
| 20 | barbed-end actin filament capping (GO:0051016) | 3.53633132 |
| 21 | positive regulation of leukocyte degranulation (GO:0043302) | 3.51466805 |
| 22 | ceramide catabolic process (GO:0046514) | 3.50855177 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.36631639 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.36631639 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.36631639 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.36631639 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.36631639 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 3.36631639 |
| 29 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.22888953 |
| 30 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21752282 |
| 31 | response to thyroid hormone (GO:0097066) | 3.17971632 |
| 32 | regulation of cholesterol storage (GO:0010885) | 3.15835349 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.14730926 |
| 34 | L-amino acid import (GO:0043092) | 3.13333252 |
| 35 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.09784873 |
| 36 | adenosine receptor signaling pathway (GO:0001973) | 3.06150888 |
| 37 | cellular extravasation (GO:0045123) | 3.02803184 |
| 38 | positive regulation of regulated secretory pathway (GO:1903307) | 3.02376782 |
| 39 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.02324274 |
| 40 | negative regulation of cell killing (GO:0031342) | 2.98867578 |
| 41 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.98867578 |
| 42 | N-acetylneuraminate metabolic process (GO:0006054) | 2.95278402 |
| 43 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.93856622 |
| 44 | synaptic vesicle exocytosis (GO:0016079) | 2.92787304 |
| 45 | response to muramyl dipeptide (GO:0032495) | 2.87046914 |
| 46 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.86938084 |
| 47 | regulation of mast cell activation (GO:0033003) | 2.85959533 |
| 48 | detection of molecule of bacterial origin (GO:0032490) | 2.85180976 |
| 49 | detection of other organism (GO:0098543) | 2.83463776 |
| 50 | regulation of superoxide anion generation (GO:0032928) | 2.83386558 |
| 51 | phagosome maturation (GO:0090382) | 2.83166296 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80121603 |
| 53 | immunoglobulin mediated immune response (GO:0016064) | 2.75069527 |
| 54 | regulation of ARF protein signal transduction (GO:0032012) | 2.74285868 |
| 55 | membrane lipid catabolic process (GO:0046466) | 2.73503181 |
| 56 | regulation of early endosome to late endosome transport (GO:2000641) | 2.73117198 |
| 57 | myeloid cell activation involved in immune response (GO:0002275) | 2.72175295 |
| 58 | sphingolipid catabolic process (GO:0030149) | 2.71379757 |
| 59 | ganglioside metabolic process (GO:0001573) | 2.69784211 |
| 60 | response to acidic pH (GO:0010447) | 2.67151114 |
| 61 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.66308429 |
| 62 | regulation of macrophage chemotaxis (GO:0010758) | 2.66096849 |
| 63 | detection of external biotic stimulus (GO:0098581) | 2.64117553 |
| 64 | positive regulation of macrophage cytokine production (GO:0060907) | 2.63627805 |
| 65 | synaptic vesicle maturation (GO:0016188) | 2.62015010 |
| 66 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.61942508 |
| 67 | macrophage activation (GO:0042116) | 2.61937530 |
| 68 | amino acid import (GO:0043090) | 2.61906886 |
| 69 | apoptotic cell clearance (GO:0043277) | 2.60924311 |
| 70 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.60384976 |
| 71 | regulation of monocyte chemotaxis (GO:0090025) | 2.60022011 |
| 72 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.58379490 |
| 73 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.56603548 |
| 74 | detection of bacterium (GO:0016045) | 2.55608569 |
| 75 | neuromuscular process controlling balance (GO:0050885) | 2.55324898 |
| 76 | regulation of macrophage cytokine production (GO:0010935) | 2.53506903 |
| 77 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.53297942 |
| 78 | granulocyte activation (GO:0036230) | 2.52578578 |
| 79 | pinocytosis (GO:0006907) | 2.49772570 |
| 80 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.47695438 |
| 81 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.47625862 |
| 82 | lytic vacuole organization (GO:0080171) | 2.47547898 |
| 83 | lysosome organization (GO:0007040) | 2.47547898 |
| 84 | positive regulation of protein dephosphorylation (GO:0035307) | 2.47129833 |
| 85 | cortical actin cytoskeleton organization (GO:0030866) | 2.47039168 |
| 86 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.47027863 |
| 87 | regulation of mononuclear cell migration (GO:0071675) | 2.46631465 |
| 88 | negative regulation of interleukin-17 production (GO:0032700) | 2.38509174 |
| 89 | adhesion of symbiont to host cell (GO:0044650) | 2.38109111 |
| 90 | virion attachment to host cell (GO:0019062) | 2.38109111 |
| 91 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.37700039 |
| 92 | respiratory burst (GO:0045730) | 2.37554748 |
| 93 | myeloid dendritic cell differentiation (GO:0043011) | 2.36949431 |
| 94 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.35697977 |
| 95 | detection of biotic stimulus (GO:0009595) | 2.34344387 |
| 96 | positive regulation of antigen processing and presentation (GO:0002579) | 2.33807129 |
| 97 | macrophage differentiation (GO:0030225) | 2.32611091 |
| 98 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.31325593 |
| 99 | positive regulation of Rap GTPase activity (GO:0032854) | 2.30796520 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.29806358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.19995097 |
| 2 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.18708875 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.95970103 |
| 4 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.87361337 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.69090539 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.48600386 |
| 7 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.47034644 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41658501 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39051883 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.33666985 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.22458952 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18682494 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.14794965 |
| 14 | KDM2B_26808549_Chip-Seq_K562_Human | 2.08484743 |
| 15 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.04481296 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.02803980 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96722533 |
| 18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.96265128 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.94546896 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89671809 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86630542 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84576239 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75716705 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75441183 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.73164265 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71366875 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69795442 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68785860 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68535488 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.68459055 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66765987 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66311552 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64994855 |
| 34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.63219480 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60599786 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.60067829 |
| 37 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.56337330 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56103890 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54120509 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52475468 |
| 41 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51588541 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49695783 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.48413604 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48377613 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42647730 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.41399404 |
| 47 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40411586 |
| 48 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40105058 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.39303160 |
| 50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35451730 |
| 51 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35426742 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33706749 |
| 53 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32022000 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31327660 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30883592 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30755992 |
| 57 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29982993 |
| 58 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29944317 |
| 59 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.29191755 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.29082227 |
| 61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26707844 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24869962 |
| 63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24158591 |
| 64 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23597514 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.23528367 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.23158063 |
| 67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20525245 |
| 68 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.20490312 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17891252 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17772555 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17557066 |
| 72 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16251599 |
| 73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14056461 |
| 74 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.12809691 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11947863 |
| 76 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11724754 |
| 77 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.11648427 |
| 78 | MAF_26560356_Chip-Seq_TH2_Human | 1.10576390 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09776539 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09347280 |
| 81 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.07749340 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06862993 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06620088 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05887676 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03768060 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03745745 |
| 87 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03263552 |
| 88 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02364756 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01525390 |
| 90 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.01291048 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00867871 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99594923 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99485968 |
| 94 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.98347628 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97891701 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97528333 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96557001 |
| 98 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.96250130 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94652229 |
| 100 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94293050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.05498108 |
| 2 | MP0003172_abnormal_lysosome_physiology | 4.27984585 |
| 3 | MP0000604_amyloidosis | 3.33953736 |
| 4 | MP0003303_peritoneal_inflammation | 3.19482034 |
| 5 | MP0003329_amyloid_beta_deposits | 3.12150760 |
| 6 | MP0009840_abnormal_foam_cell | 3.04680788 |
| 7 | MP0003690_abnormal_glial_cell | 2.99201298 |
| 8 | MP0006082_CNS_inflammation | 2.99041198 |
| 9 | MP0003436_decreased_susceptibility_to | 2.70006284 |
| 10 | MP0002419_abnormal_innate_immunity | 2.53235748 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.43404664 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.43178250 |
| 13 | MP0003075_altered_response_to | 2.33475465 |
| 14 | MP0000920_abnormal_myelination | 2.15294579 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.09932965 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.06176010 |
| 17 | MP0005025_abnormal_response_to | 1.96002852 |
| 18 | MP0000343_altered_response_to | 1.92892896 |
| 19 | MP0009278_abnormal_bone_marrow | 1.89304010 |
| 20 | MP0003300_gastrointestinal_ulcer | 1.88844381 |
| 21 | MP0005671_abnormal_response_to | 1.84199697 |
| 22 | MP0002998_abnormal_bone_remodeling | 1.83809597 |
| 23 | MP0008260_abnormal_autophagy | 1.82758085 |
| 24 | MP0003724_increased_susceptibility_to | 1.79247410 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.75464162 |
| 26 | MP0000685_abnormal_immune_system | 1.75099333 |
| 27 | MP0003879_abnormal_hair_cell | 1.70425369 |
| 28 | MP0001790_abnormal_immune_system | 1.67169042 |
| 29 | MP0005387_immune_system_phenotype | 1.67169042 |
| 30 | MP0002064_seizures | 1.63470242 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.61258831 |
| 32 | MP0009785_altered_susceptibility_to | 1.60165985 |
| 33 | MP0005451_abnormal_body_composition | 1.59697043 |
| 34 | MP0003634_abnormal_glial_cell | 1.58251972 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.57634385 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.56859317 |
| 37 | MP0004510_myositis | 1.55216346 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.54074306 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.48318124 |
| 40 | MP0004947_skin_inflammation | 1.46795065 |
| 41 | MP0002723_abnormal_immune_serum | 1.42887509 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.37540047 |
| 43 | MP0001819_abnormal_immune_cell | 1.36395642 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.35482475 |
| 45 | MP0005409_darkened_coat_color | 1.33449826 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.31326221 |
| 47 | MP0004270_analgesia | 1.30771534 |
| 48 | MP0005166_decreased_susceptibility_to | 1.30362128 |
| 49 | MP0003633_abnormal_nervous_system | 1.26376864 |
| 50 | MP0001800_abnormal_humoral_immune | 1.25660525 |
| 51 | MP0003632_abnormal_nervous_system | 1.23289380 |
| 52 | MP0001849_ear_inflammation | 1.23112222 |
| 53 | MP0005310_abnormal_salivary_gland | 1.22940865 |
| 54 | MP0001853_heart_inflammation | 1.22729692 |
| 55 | MP0004381_abnormal_hair_follicle | 1.21056576 |
| 56 | MP0003635_abnormal_synaptic_transmissio | 1.19159516 |
| 57 | MP0003828_pulmonary_edema | 1.16607135 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.14860650 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.14860650 |
| 60 | MP0005257_abnormal_intraocular_pressure | 1.12940197 |
| 61 | MP0003631_nervous_system_phenotype | 1.11791110 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.11218898 |
| 63 | MP0000858_altered_metastatic_potential | 1.09313824 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.08834002 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.08002177 |
| 66 | MP0004130_abnormal_muscle_cell | 1.07408448 |
| 67 | MP0000371_diluted_coat_color | 1.03953891 |
| 68 | MP0003448_altered_tumor_morphology | 1.03633858 |
| 69 | MP0002063_abnormal_learning/memory/cond | 1.03602769 |
| 70 | MP0008569_lethality_at_weaning | 1.03129767 |
| 71 | MP0009764_decreased_sensitivity_to | 1.00400107 |
| 72 | MP0002405_respiratory_system_inflammati | 0.96536213 |
| 73 | MP0008874_decreased_physiological_sensi | 0.96010305 |
| 74 | MP0002139_abnormal_hepatobiliary_system | 0.94444597 |
| 75 | MP0008469_abnormal_protein_level | 0.94080938 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 0.86225339 |
| 77 | MP0002229_neurodegeneration | 0.86106665 |
| 78 | MP0000716_abnormal_immune_system | 0.84331605 |
| 79 | MP0003091_abnormal_cell_migration | 0.82357358 |
| 80 | MP0005423_abnormal_somatic_nervous | 0.81626253 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.80343743 |
| 82 | MP0003880_abnormal_central_pattern | 0.79274462 |
| 83 | MP0001440_abnormal_grooming_behavior | 0.78936916 |
| 84 | MP0010155_abnormal_intestine_physiology | 0.77244936 |
| 85 | MP0001958_emphysema | 0.77114895 |
| 86 | MP0003279_aneurysm | 0.76274292 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.75681616 |
| 88 | MP0000747_muscle_weakness | 0.75145242 |
| 89 | MP0004858_abnormal_nervous_system | 0.74546316 |
| 90 | MP0009745_abnormal_behavioral_response | 0.74267155 |
| 91 | MP0002090_abnormal_vision | 0.73868234 |
| 92 | MP0004742_abnormal_vestibular_system | 0.72878469 |
| 93 | MP0009046_muscle_twitch | 0.71998795 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.71587303 |
| 95 | MP0001851_eye_inflammation | 0.71129247 |
| 96 | MP0005390_skeleton_phenotype | 0.68858446 |
| 97 | MP0001970_abnormal_pain_threshold | 0.67081459 |
| 98 | MP0002734_abnormal_mechanical_nocicepti | 0.65907480 |
| 99 | MP0000681_abnormal_thyroid_gland | 0.63437530 |
| 100 | MP0002572_abnormal_emotion/affect_behav | 0.63195449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 7.17835593 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.17835593 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.17835593 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.61341639 |
| 5 | Neurofibrillary tangles (HP:0002185) | 4.81177100 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.72059888 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.51514063 |
| 8 | Dysostosis multiplex (HP:0000943) | 4.50776583 |
| 9 | Mutism (HP:0002300) | 4.16256519 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.01385842 |
| 11 | Loss of speech (HP:0002371) | 3.89510889 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 3.87436058 |
| 13 | Disinhibition (HP:0000734) | 3.78727970 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.76174601 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.69082299 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.64024221 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.60249383 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.58178569 |
| 19 | Neuronal loss in central nervous system (HP:0002529) | 3.49654675 |
| 20 | Apathy (HP:0000741) | 3.47787445 |
| 21 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.40595870 |
| 22 | Diminished motivation (HP:0000745) | 3.38482813 |
| 23 | Axonal loss (HP:0003447) | 3.36855670 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.31819522 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.31819522 |
| 26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.31819522 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.27292425 |
| 28 | Mucopolysacchariduria (HP:0008155) | 3.21004541 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.21004541 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.84997459 |
| 31 | Diplopia (HP:0000651) | 2.71260564 |
| 32 | Abnormality of binocular vision (HP:0011514) | 2.71260564 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 2.70607008 |
| 34 | Amyloidosis (HP:0011034) | 2.70388489 |
| 35 | Upper motor neuron abnormality (HP:0002127) | 2.62793468 |
| 36 | Visual hallucinations (HP:0002367) | 2.62459859 |
| 37 | Dementia (HP:0000726) | 2.60153463 |
| 38 | Nuclear cataract (HP:0100018) | 2.57208753 |
| 39 | Purpura (HP:0000979) | 2.55726820 |
| 40 | Global brain atrophy (HP:0002283) | 2.54718485 |
| 41 | Inappropriate behavior (HP:0000719) | 2.42452098 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40592776 |
| 43 | Obstructive lung disease (HP:0006536) | 2.40592776 |
| 44 | Abnormality of the periventricular white matter (HP:0002518) | 2.39326264 |
| 45 | Thoracic kyphosis (HP:0002942) | 2.37656690 |
| 46 | Peripheral hypomyelination (HP:0007182) | 2.28003212 |
| 47 | Myocardial infarction (HP:0001658) | 2.26659481 |
| 48 | Gingivitis (HP:0000230) | 2.26107612 |
| 49 | Personality changes (HP:0000751) | 2.25401661 |
| 50 | Recurrent skin infections (HP:0001581) | 2.24921738 |
| 51 | Ocular albinism (HP:0001107) | 2.17397526 |
| 52 | Agnosia (HP:0010524) | 2.12014366 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.11003716 |
| 54 | Progressive neurologic deterioration (HP:0002344) | 2.10753508 |
| 55 | Polygenic inheritance (HP:0010982) | 2.09627792 |
| 56 | Retinal atrophy (HP:0001105) | 2.08618236 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.05912958 |
| 58 | Obstructive sleep apnea (HP:0002870) | 2.04760404 |
| 59 | Pathologic fracture (HP:0002756) | 2.01439426 |
| 60 | Peripheral demyelination (HP:0011096) | 1.98896152 |
| 61 | Ankle clonus (HP:0011448) | 1.98097871 |
| 62 | Myositis (HP:0100614) | 1.94817038 |
| 63 | Cellulitis (HP:0100658) | 1.94428341 |
| 64 | Glomerulonephritis (HP:0000099) | 1.93596026 |
| 65 | Hyperacusis (HP:0010780) | 1.93329861 |
| 66 | Spontaneous hematomas (HP:0007420) | 1.93146385 |
| 67 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89722634 |
| 68 | Stomatitis (HP:0010280) | 1.84351398 |
| 69 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84213358 |
| 70 | Memory impairment (HP:0002354) | 1.83525242 |
| 71 | Abnormality of the thoracic spine (HP:0100711) | 1.82564519 |
| 72 | Cerebral aneurysm (HP:0004944) | 1.82509977 |
| 73 | Urinary incontinence (HP:0000020) | 1.82381380 |
| 74 | Myokymia (HP:0002411) | 1.81868184 |
| 75 | Annular pancreas (HP:0001734) | 1.80694746 |
| 76 | Iris hypopigmentation (HP:0007730) | 1.79317056 |
| 77 | Truncal ataxia (HP:0002078) | 1.79249397 |
| 78 | Rapidly progressive (HP:0003678) | 1.78909020 |
| 79 | Bone pain (HP:0002653) | 1.78705066 |
| 80 | Action tremor (HP:0002345) | 1.78428260 |
| 81 | Cardiomegaly (HP:0001640) | 1.77544115 |
| 82 | Orchitis (HP:0100796) | 1.77417210 |
| 83 | Vertebral compression fractures (HP:0002953) | 1.74670711 |
| 84 | Asymmetric septal hypertrophy (HP:0001670) | 1.73656401 |
| 85 | Progressive visual loss (HP:0000529) | 1.73046857 |
| 86 | Slow saccadic eye movements (HP:0000514) | 1.72608263 |
| 87 | Increased serum ferritin (HP:0003281) | 1.71212945 |
| 88 | Increased IgE level (HP:0003212) | 1.67704542 |
| 89 | J-shaped sella turcica (HP:0002680) | 1.67451516 |
| 90 | Thin bony cortex (HP:0002753) | 1.64843788 |
| 91 | Recurrent fungal infections (HP:0002841) | 1.64760373 |
| 92 | Urticaria (HP:0001025) | 1.63431291 |
| 93 | Abnormal eating behavior (HP:0100738) | 1.62315818 |
| 94 | Depression (HP:0000716) | 1.60994271 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.60014145 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 1.60014145 |
| 97 | Petechiae (HP:0000967) | 1.58044603 |
| 98 | Insomnia (HP:0100785) | 1.57936774 |
| 99 | Rigidity (HP:0002063) | 1.57610406 |
| 100 | Onion bulb formation (HP:0003383) | 1.57574598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.55351401 |
| 2 | PRPF4B | 3.12879094 |
| 3 | TRIB3 | 2.37007980 |
| 4 | BLK | 2.26760283 |
| 5 | MAP3K11 | 2.19619881 |
| 6 | IRAK3 | 2.09313470 |
| 7 | MAP3K13 | 2.06118044 |
| 8 | ERN1 | 1.94809308 |
| 9 | MAP2K3 | 1.81732884 |
| 10 | CAMKK1 | 1.76016998 |
| 11 | NME2 | 1.75796115 |
| 12 | SIK2 | 1.62167733 |
| 13 | RIPK1 | 1.61429515 |
| 14 | PAK6 | 1.60994421 |
| 15 | FES | 1.60305323 |
| 16 | CAMK1D | 1.60105736 |
| 17 | DAPK2 | 1.56394994 |
| 18 | ARAF | 1.41571137 |
| 19 | TYK2 | 1.40211316 |
| 20 | FGR | 1.39261291 |
| 21 | TGFBR2 | 1.38483694 |
| 22 | MARK2 | 1.37308246 |
| 23 | MAP3K9 | 1.37303672 |
| 24 | CSK | 1.36710709 |
| 25 | DDR2 | 1.34367926 |
| 26 | TAOK1 | 1.33366993 |
| 27 | PRKD3 | 1.33364333 |
| 28 | MAP4K1 | 1.30146755 |
| 29 | CSF1R | 1.28197128 |
| 30 | TAOK2 | 1.27403945 |
| 31 | MAP3K14 | 1.26577311 |
| 32 | MAPK12 | 1.25042970 |
| 33 | KSR2 | 1.24947697 |
| 34 | KIT | 1.23200280 |
| 35 | GRK7 | 1.21889701 |
| 36 | TNK2 | 1.18362190 |
| 37 | CAMKK2 | 1.18134227 |
| 38 | TBK1 | 1.17763687 |
| 39 | ICK | 1.17278465 |
| 40 | MAP3K1 | 1.16054765 |
| 41 | RPS6KA2 | 1.16030364 |
| 42 | CDC42BPA | 1.15562388 |
| 43 | PDPK1 | 1.15524040 |
| 44 | MAP3K3 | 1.15045243 |
| 45 | EEF2K | 1.08902755 |
| 46 | ABL2 | 1.08694193 |
| 47 | NTRK3 | 1.07413888 |
| 48 | ZAP70 | 1.06907122 |
| 49 | CAMK1G | 0.95082978 |
| 50 | PRKD2 | 0.94224430 |
| 51 | TYRO3 | 0.92146117 |
| 52 | SYK | 0.91893872 |
| 53 | SMG1 | 0.90543806 |
| 54 | IRAK4 | 0.89396233 |
| 55 | PDK1 | 0.88771344 |
| 56 | MATK | 0.88259243 |
| 57 | SIK1 | 0.86516655 |
| 58 | IRAK2 | 0.81791056 |
| 59 | MAP3K6 | 0.80090745 |
| 60 | TESK1 | 0.77722654 |
| 61 | SGK3 | 0.76719556 |
| 62 | PIM2 | 0.76506915 |
| 63 | RPS6KL1 | 0.74891636 |
| 64 | RPS6KC1 | 0.74891636 |
| 65 | MARK1 | 0.74097724 |
| 66 | MOS | 0.72878344 |
| 67 | MAP2K4 | 0.71361451 |
| 68 | TTN | 0.70170507 |
| 69 | LIMK1 | 0.70058833 |
| 70 | HCK | 0.68287112 |
| 71 | UHMK1 | 0.67121596 |
| 72 | JAK2 | 0.65303393 |
| 73 | MAP2K6 | 0.63821120 |
| 74 | MAPK4 | 0.63697143 |
| 75 | TESK2 | 0.62802520 |
| 76 | NTRK1 | 0.61892458 |
| 77 | RPS6KA6 | 0.61606368 |
| 78 | CDK5 | 0.59539079 |
| 79 | SGK223 | 0.59014420 |
| 80 | SGK494 | 0.59014420 |
| 81 | NTRK2 | 0.58534234 |
| 82 | CAMK1 | 0.58334022 |
| 83 | LYN | 0.57911362 |
| 84 | EPHA4 | 0.56474042 |
| 85 | MAPK7 | 0.54811010 |
| 86 | BTK | 0.54700855 |
| 87 | PRKG2 | 0.54542245 |
| 88 | JAK1 | 0.54333324 |
| 89 | PRKCH | 0.53753005 |
| 90 | IKBKB | 0.52459288 |
| 91 | ALK | 0.52321351 |
| 92 | FYN | 0.52055796 |
| 93 | LATS2 | 0.50868914 |
| 94 | BRAF | 0.50647742 |
| 95 | GRK6 | 0.50256661 |
| 96 | CAMK4 | 0.48091388 |
| 97 | STK11 | 0.46844535 |
| 98 | PDGFRA | 0.44014351 |
| 99 | JAK3 | 0.43145243 |
| 100 | MAP3K2 | 0.42995694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.73120963 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.15878172 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.35552200 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32171605 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.20384883 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.96778321 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.96201552 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94623579 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 1.89739514 |
| 10 | Phagosome_Homo sapiens_hsa04145 | 1.71848231 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65902110 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.63724787 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63714081 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.56831316 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.53433985 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.44967114 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.41817373 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.29148681 |
| 19 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.29031587 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25975504 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.25337497 |
| 22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24206196 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.22019387 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21804835 |
| 25 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.21741322 |
| 26 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21555973 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20363802 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.20276157 |
| 29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.19288538 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.18980949 |
| 31 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15018685 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.13674101 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13517842 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10617448 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.07396465 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04032226 |
| 37 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.02999049 |
| 38 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99603340 |
| 39 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.96260774 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96034596 |
| 41 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95747625 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92237263 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90830818 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89387517 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87065079 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86926541 |
| 47 | Endocytosis_Homo sapiens_hsa04144 | 0.86402520 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85863405 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84235128 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79854313 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.78553407 |
| 52 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.77466703 |
| 53 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76402820 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 0.75030234 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75017555 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 0.74373029 |
| 57 | Morphine addiction_Homo sapiens_hsa05032 | 0.74342248 |
| 58 | Glioma_Homo sapiens_hsa05214 | 0.74059477 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73050421 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72303904 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71802488 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69729503 |
| 63 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.69450628 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69273747 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67855898 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66931618 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.66088518 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66079538 |
| 69 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.65966842 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65835366 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65806347 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65505900 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.65230897 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65104531 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.64049864 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63683284 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.63190741 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61793817 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.61438075 |
| 80 | Legionellosis_Homo sapiens_hsa05134 | 0.60870074 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60714567 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60509618 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59718238 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.59295201 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59288769 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.58691482 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57198886 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57082752 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56944007 |
| 90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56877964 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56586961 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55975594 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54911091 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53100204 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.51625997 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50398990 |
| 97 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.49494182 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.48836630 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48822705 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48742711 |

